Actively Recruiting
Virtual Agent Feasibility in Oncology Patients (NTT Data)
Led by Duke University · Updated on 2026-03-18
36
Participants Needed
1
Research Sites
17 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to compare the use of a virtual agent vs. a human agent when onboarding oncology patients over the telephone to Remote Patient Monitoring (RPM) devices. RPM devices are instruments that a patient can use to measure their own weight and vital signs. Both the virtual and human agents will be available by telephone to instruct the patient on how to use the RPM devices to measure weight, blood pressure, heart rate, temperature, and oxygen saturation. Patients will be randomized to either the virtual or human agent, have assessments of their medical and oncological history, overall well-being, body measurements, and vital signs, and will complete questionnaires about their experience.
CONDITIONS
Official Title
Virtual Agent Feasibility in Oncology Patients (NTT Data)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Willing and able to provide written informed consent and HIPAA authorization for the release of personal health information
- Age 18 or older
- Diagnosis of solid tumor cancer
- Planning to return to Duke Cancer Center clinic for three days in a row or willing to return voluntarily
- Eastern Cooperative Oncology Group (ECOG) score of 0-2
- Native fluency in spoken English or equivalent proficiency
- Vitals within specified ranges: weight up to 180 kg, systolic blood pressure up to 300 mmHg, pulse rate 40-200 bpm, oxygen saturation 70-100%, temperature 34.0-42.2 °C
- Arm circumference between 22 and 42 cm
You will not qualify if you...
- Vision, speech, auditory, physical, cognitive, or other impairments that could interfere with using the remote monitoring device or agent
- Presence of implanted pacemaker, arterio-venous shunt, history of mastectomy or lymph node clearance, severe blood flow problems, blood disorders, or severe circulatory deficit in the arm
- Pregnancy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Duke University Medical Center
Durham, North Carolina, United States, 27710
Actively Recruiting
Research Team
L
Laura Alder, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here